Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
International Journal of Cancer|August 22, 2018
PCNA-associated factor P15<sup>PAF</sup> , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patientsChengjuan Jin, Zhaojian Liu, Yingwei Li, et al.
Journal of Translational Medicine|October 8, 2021
Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancerJinyu Meng, Jin Peng, Jie Feng, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2017
The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer PatientsXiaohua Wu, Lingying Wu, Beihua Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline <i>BRCA1/2</i> Mutation and Platinum-sensitive Recurrent Ovarian CancerNing Li, Hualei Bu, Jihong Liu, et al.
Pageof 3